Bio
Prior to joining CAS, Gilles held various executive positions including as Vice President and General Manager at Milacron; Business Director at DuPont/Axalta; and as the Global Business Development Manager at 3M, as well as multiple other roles across R&D, business and sales functions in the aerospace, oil & gas, industrial, optical and electronics industries. Gilles holds a Ph.D. in chemistry from the University of Montreal, Canada, an MBA from HEC school, Canada, a bachelor’s degrees in chemistry and material sciences from the Université de Pau, France, and is a Six Sigma Black Belt.
![](https://cdn.prod.website-files.com/650867962272bf8f15c1034b/659589c6545dfc0b489eff93_RNA-HERO-1920x1080.webp)
Biotechnology
RNA medicines: what technologies are investors funding?
RNA medicine has spawned many new technologies and approaches. Examine market trends and where investors are funneling their money.
![](https://cdn.prod.website-files.com/650867962272bf8f15c1034b/6595919f9a1ee6554294805f_nuclear-thumbnail.webp)
Sustainability
Is nuclear energy critical in solving climate change?
Nuclear energy could play a part in solving climate change, but there are still hurdles and challenges that must be overcome.